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ABSTRACT - A 21 year old male ingested podophyllin in a suicide attempt. The disorder was marked by 
seizures, coma, peripheral neuropathy, renal failure and acute necrotizing myopathy, an unusual finding. The 
coma and systemic disturbances resolved within three weeks. The myopathy resolved in 7 weeks, demonstrating 
a high capacity of muscle recuperation. The sensorimotor peripheral neuropathy persisted until the patient's 
death 9 weeks after the ingestion, due to septicemia. This report confirms the transient central neurotoxicity of 
podophyllin and persistent peripheral neurotoxicity of podophyllin, and describes a reversible necrotizing 
myopathy associated to mitochondrial abnormalities, a still unreported feature of podophyllin toxicity. 
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Miopatia necrotizante aguda e toxicidade por podofilina: relato de caso fatal 
RESUMO - Paciente de 21 anos, sexo masculino, ingeriu 20 mL de podofilina a 25% como tentativa de suicídio. 
O quadro clínico caracterizou-se por crises convulsivas, coma, neuropatia periférica, insuficiência renal e miopatia 
necrotizante aguda. O estado de coma e os distúrbios sistêmicos resolveram-se em 3 semanas. A miopatia 
resolveu-se em 7 semanas, demonstrando uma alta capacidade de recuperação muscular. A neuropatia periférica 
sensitivo-motora persistiu até o óbito do paciente, por septicemia, 9 semanas após a ingestão da podofilina. Esta 
descrição confirma os achados de literatura com alterações transitórias do sistema nervoso central e persistentes 
do nervo periférico relacionadas à podofilina, e descreve uma miopatia necrotizante associada com anormalidades 
mitocondriais, mas de caráter reversível, característica até então não reportada de toxicidade pela podofilina. 
PALAVRAS-CHAVE: podofilina, toxicidade aguda, miopatia. 
Miopatia necrotizante aguda e toxicidade por podoillina: relato de caso fatal 
RESUMO - Paciente de 21 anos, sexo masculino, ingeriu 20 mL de podoillina a 25% como tentativa de suicídio. 
O quadro clínico caracterizou-se por crises convulsivas, coma, neuropatia periférica, insuficiência renal e miopatia 
necrotizante aguda. O estado de coma e os distúrbios sistêmicos resolveram-se em 3 semanas. A miopatia 
resolveu-se em 7 semanas, demonstrando uma alta capacidade de recuperação muscular. A neuropatia periférica 
sensitivo-motora persistiu até o óbito do paciente, por septicemia, 9 semanas após a ingestão da podofilina. Esta 
descrição confirma os achados de literatura com alterações transitórias do sistema nervoso central e persistentes 
do nervo periférico relacionadas à podofilina, e descreve uma miopatia necrotizante associada com anormalidades 
mitocondriais, mas de caráter reversível, característica até então não reportada de toxicidade pela podofilina. 
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Podophyllin peltatum (Mayapple plant) is a source of podophyllotoxin, an antimicrotubule 
agent, and is a constituent of herbal preparations used in some parts of the world as cathartics and in 
treatment of inflammation6. Podophyllin is now a resin commonly used in the topical treatment of 
warts and condylomata. Systemic toxicity may result from either topical exposure4-2""22 or 
ingestion 3 ' 5 ' 7 1 2 1 6 ' ' 7 ' 2 3 of this alkaloid. Systemic manifestations of toxicity include nausea, vomiting, 
and diarrhea3"5-8-10-12-16"23, followed by marrow suppression413 ,20'21'23, renal3 2 3 and hepatic1318-20'21-23 failure. 
Neurotoxic effects may involve the central and peripheral nervous system, with impairment of 
consciousness3-5-7-8121319-22, seizures210, and sensory, motor, and autonomic neuropathy4-7-8 1 3 1 6 19-20-22-23. 
The clinical course is sometimes fatal3-7-12-22-23. 
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We report a patient with podophyllin intoxication who exhibited many of these manifestations, 
and who displayed an acute and reversible necrotizing myopathy, a feature not previously reported. 
CASE REPORT 
This 21 year old man drank about 20 mL of 25% podophyllin resin solution in ethyl alcohol in a suicide 
attempt. Later that day he had mild headache, nausea and diarrhea. On the next day he was drowsy. In the 
ensuing three days he became disoriented and confused and progressed into a coma. There was no history of 
previous psychiatric disorder, head trauma, drug or alcohol abuse, or other toxin exposure. Upon admission his 
pulse was 70/min, blood pressure 130/80, respiration rate 22/min, and axillary temperature 40° C. There was no 
response to verbal stimuli and minimal response to pain in all 4 extremities. There was no attempt to withdraw 
the limb from the painful stimulus. Tone was diminished and deep tendon reflexes were absent No muscle 
atrophy or fasciculations were detected. Plantar responses were flexor. Cranial nerve examination was 
unremarkable and ocular fundi were normal. Minutes later the patient had a tonic-clonic generalized seizure. 
Initial laboratory studies included, hemoglobin 15.8 g/dL, hematocrit 48%, WBC 23200/mm3 (98% 
polymorphonuclears, 1% lymphocytes, 1% eosinophils) platelets 300 000/mm3, sedimation rate 5 mm/h, urea 
31 mg/dL, creatinine 1 mg/dL, Na 139 mEq/dL, K 3.6 mEq/dL, SGOT 450 units (normal range 7-40), SGPT 
200 units (normal range 0-16), CK 5 810 U/dL (normal up to 50 U), LDH 1 127 U/L (normal range 90-250). 
Urinalysis was normal. Serum and standard toxicology screens, urinary porphyrin, and heavy metal screens 
were negative. A lumbar puncture revealed a CSF opening pressure of 120 mm H 20 with 2 red cells/mm3, 2 
white cells/mmJ, protein 30 mg/dL and glucose 68 mg/dL. An initial CT brain scan was normal. By the 3rd 
hospital day the patient became progressively more responsive, and by the 10th day he was completely alert, 
with well preserved cortical functions. However, the muscle weakness continued to deteriorate and by the 10th 
day he had a flaccid, areflexic quadriplegia with distal muscle atrophy in the 4 limbs. There was loss of superficial 
sensibility in the extremities of the limbs. His serum enzymes started to drop and went back to normal by the 
30th day. At this time he experienced some improvement in muscle power. On the 46th days he could barely lift 
his arms and legs against gravity. 
The patient's clinical course worsened on the 3rd day with hypertension (220/110 mm/Hg), and tachycardia 
(120/min), on the 11th day with hyperhemic esophagitis and upper gastrointestinal bleeding, on the 12th day 
with kidney failure, pneumonia and pulmonary insufficiency leading to mechanical ventilation and antibiotic 
therapy. On the 15th day he had cardiac failure that was interpreted as myocarditis. Dialysis was not needed. 
During the course of his illness, disturbances in serum electrolytes were not detected. On the 69th day he died. 
Post mortem examination showed septicemia. Unfortunately no muscle, peripheral nerve or root was examined. 
No abnormalities could be evidenced in the liver, heart or kidney. 
Muscle biopsies. Muscle biopsies from deltoid were performed on the 20th and 46th days and were 
processed according to standard criteria". The first showed many necrotic muscle fibers in all fascicles, with 
few macrophages and lymphocytes, and marked mitochondrial abnormalities on trichrome (Fig 1) and SDH 
stainings. These findings were interpreted as an acute necrotizing myopathy associated to mitochondrial 

dysfunction. The second biopsy showed the presence of few scattered atrophic muscle fibers, nucleus centralization 
(Fig 2) and fiber type-grouping, signs of a neurogenic process. No more necrotic fibers were seen and the 
mitochondrial abnormalities were still present, but less intense. 
Electromyographic and nerve conduction study. EMG was performed using a TECA TD-10 model, on 
the 46th hospital day, and disclosed fibrillations, positive sharp waves and almost no voluntary muscle potentials 
in all muscles examined in the 4 extremities. The nerve conduction study showed a severe and predominantly 
neuropathy. Sensory nerve potentials were unobtainable in the sural, median and ulnar nerves. Motor conduction 
velocity was decreased in the peroneal, median and ulnar nerves. 
DISCUSSION 
Podophyllin resin contains numerous compounds but the toxic agent is thought to be 
podophyllotoxin, a highly lipid-soluble b-d-glycoside molecule that crosses the cell membranes 
with ease. This substance and its derivatives have a colchicine-like effect, arresting the mitotic 
spindle24. Podophyllin is absorbed readily through the gastrointestinal tract. Topical application may 
result in significant systemic absorption, especially if it is applied to a large area allowed to remain 
in contact for a prologned period of time, is apllied to friable or recently biopsied condylomata, or if 
inadvertently administered to surrounding skin or mucous membranes21. The fatal dose of podophyllin 
resin for humans has been estimated to be 0.3g to 0.6g, or as little as one half teaspoon of 25% 
podophyllin resin in benzoin tincture9. 
Both systemic and neurological disturbances occur from severe podophyllin toxicity. The initial 
manifestations exhibited by our patient, headache, nausea, diarrhea, and altered sensorium are among 
those previously described18'20. Later in the course, our patient showed transient hypertension, tachycardia, 
renal failure, pulmonary insufficiency and cardiac abnormalities, all known complications of the 
toxicity3 20-22. The central nervous system toxicity is usually transient and reversible over a period of up 
to ten days*18, but deep coma leading to a fatal outcome322 or severe encephalopathy characterized by 
irreversible cognitive dysfunction may also occur3. The peripheral neurotoxicity shows frequently a 
protracted course13,20. Both these features have been well exemplified by our patient. 
Sensorimotor mixed neuropathy with tetraplegia, areflexia, hypotonia, and sensory and 
automatic disturbances shown here followed the same course described in other patients4'713,1618. 
The course of the neuropathy is chronic and the recovery is delayed16, sometimes with minimal 
improvement20. Sural nerve biopsies performed in the acute phase showed loss of myelinated fibers 
and signs of axonal degeneration716. The mechanism by which podophyllin produces an axonal neuropathy 
is related to its action on microtubular proteins and consequent inhibition of axoplasmic flow. 
Our patient also exhibited an acute necrotizing myopathy, an aspect of podophyllin intoxication 
hitherto undescribed. 
He showed important weakness and wasting in his limbs as early as the 3rd day post-intoxication 
accompanied by very high serum CK, and LDH. These features were suggestive of voluntary muscle 
destruction. The first muscle biopsy on the 20th day post-intoxication confirmed our suspicion 
showing a massive muscle necrosis. Associated we found marked abnormalities in the mitochondria. 
Experimental data available showing that podophyllin interferes with protein synthesis and aerobic 
respiration14 could explain our histopathological findings in the muscle biopsy. Podophyllin appears 
to attach to cell proteins and its actions include increasing the incorporation of amino acids into protein, 
inhibition of purine synthesis, and inhibition of purine incorporation into RNA. It has also been 
found to have a direct effect on the mitochondria, being able to reduce the activity of cytochrome 
oxidase and succinoxidase14. Although podophyllin is known to act as a spindle poison, thereby blocking 
mitosis at metaphase115, the second muscle biopsy, performed 26 days after the first one, showed 
important muscle regeneration. This is most probably explained by the short half-life of the drug in 
humans as exemplified by the transient altered sensorium and usually reversible systemic manifestations. 
We wish to reinforce the potentially toxic side-effects of podophyllin and add a fatal case who 
displayed an acute necrotizing myopathy. The absence of previous descriptions of muscle involvement 
in that intoxication could be due to either a failure of recognition due to the accompanying severe 
manifestation of the PNS or to a dose-related phenomenon. 
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